Contraception

Groundbreaking new poll shows bipartisan nationwide support for contraception and IVF.

The "One Big Beautiful Bill Act" passed by Congress proposes significant changes to federal health care policies, particularly affecting access to contraception and reproductive health services. This legislation is a substantial setback for reproductive health and rights, including cuts to Medicaid and new barriers to access contraception and Planned Parenthood services.
Read More

Contraceptive, Reproductive Health Counseling Crucial for Women With CKD (chronic kidney disease )

There are key barriers to contraceptive use and reproductive health management in women with chronic kidney disease (CKD), wrote authors of research published in American Journal of Kidney Diseases. These barriers include provider discomfort because of limited training and exposure, lack of clear guidelines, and fragmented care, all of which can be addressed through preparation, education, and establishing a framework of care.1
Read More

Biomedical innovations in contraception: gaps, obstacles, and solutions for sexual and reproductive health

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in modern contraception over the past 60 years many gaps remain, and the rate of unplanned pregnancies and abortions remains high. These issues have given rise to a new era in contraception research with great opportunities and many challenges. These opportunities include new innovations, particularly in the areas of male contraception, non-hormonal female contraception, and multipurpose prevention methods that provide contraception in combination with protection against leading sexually transmitted pathogens; fast tracking new inventions currently in the pipeline by intensifying support from government,…
Read More

Decreased Hormone-Free Intervals and Amenorrhea With Low-Dose Estrogen Combined Hormonal Contraceptives

Panelists discuss how shortened hormone-free intervals (24-4 and 24-2-2 regimens) prevent ovarian reactivation and endometrial proliferation that caused breakthrough bleeding with traditional 21/7 formulations, while addressing how amenorrhea can be viewed as either a desired therapeutic outcome or concerning adverse effect depending on patient preferences.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.